Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Effects of GABA
A
compounds on mCPP drug discrimination in rats
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Effects of GABA
A
compounds on mCPP drug discrimination in rats'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Drug Discrimination
100%
Response Rate
100%
GABAA
100%
Flumazenil
100%
Ro15-4513
100%
Diazepam
50%
Alprazolam
50%
Bicuculline
50%
GABAA Antagonist
50%
Discriminative Stimulus Effects
25%
Full Agonist
25%
Discriminative Stimulus
25%
Reinforced
25%
Benzodiazepines
25%
Inverse Agonist
25%
Long-Evans Rats
25%
Benzodiazepine Site
25%
Low Response
25%
Operant Task
25%
Benzodiazepine Antagonist
25%
Benzodiazepine Agonists
25%
Pharmacology, Toxicology and Pharmaceutical Science
Flumazenil
100%
Ro15-4513
100%
Rat
100%
4 Aminobutyric Acid A Receptor Blocking Agent
50%
Diazepam
50%
Alprazolam
50%
Bicuculline
50%
Benzodiazepine
25%
Long Evans Rat
25%
Benzodiazepine Receptor Blocking Agent
25%
Benzodiazepine Receptor Stimulating Agent
25%
Benzodiazepine Receptor Inverse Stimulating Agent
25%
Table Salt
25%
Neuroscience
Drug Discrimination
100%
Ro15-4513
100%
Benzodiazepine
100%
Flumazenil
100%
Agonist
50%
Bicuculline
50%
Alprazolam
50%
Diazepam
50%
Inverse Agonist
25%
Immunology and Microbiology
Long Evans Rat
33%